Reactions 1704, p107 - 2 Jun 2018 Nausea and palpitations: case report A 78-year-old man developed nausea and palpitations during treatment with clarithromycin for primary immune thrombocytopenia [route, duration of treatment to reaction onsets and outcomes not stated]. The man, who had a history of diabetes mellitus, was diagnosed with primary immune thrombocytopenia. He started receiving treatment with clarithromycin 800 mg/day. After two weeks of treatment with clarithromycin, there was an improvement in his platelet count. However, he developed gradual nausea and palpitation secondary to clarithromycin. The man’s treatment with clarithromycin was discontinued. He received treatment with prednisolone instead of clarithromycin. A subsequent improvement in his underlying condition was noted. Author comment: "The [clarithromycin] treatment was terminated owing to gradual nausea and palpitation that are probably adverse reactions of [clarithromycin]." Ohe M, et al. Successful treatment of primary immune thrombocytopenia accompanied by diabetes mellitus treated using clarithromycin followed by prednisolone. Drug Discoveries and Therapeutics 12: 101-103, No. 2, 2018. Available from: URL: http://doi.org/10.5582/ddt.2018.01008 - Japan 803323287 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera